Preventive Effects of Ketorolac and Nephaazolin- Anthrazoline Drops on Reducing Patient's Ocular Complications

Evaluation on the Preventive Effects of Ketorolac and Nephaazolin- Anthrazoline Drops on Reducing Patient's Ocular Complications after Phacoamulsification Surgery under sedation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200217046523N1

Enrollment

Registered

2020-06-18

Start date

2020-08-19

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Age-related cataract

Interventions

Intervention 1: Intervention group1: Receiver of ketorolac. Calm retention will be the same in all patients with midazolam 0.04 kg / mg and fentanyl 1.5 mg / kg. In this group, 2 drops of ketorolac ar

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All of the Patients undergoing Phacoamulsification Surgery under sedation

Exclusion criteria

Exclusion criteria: Patients with glaucoma, uncontrolled hypertension, kidney disease, allergies to sedatives or studied Proven psycho-anxiety disorders Inability to follow up patients up to 0.5 hours after recovery History of allergy or allergic reaction to Sedatives or studies Any sensitivity to ketorolac

Design outcomes

Primary

Measure	Time frame
Ocular Complaints. Timepoint: Every 15 minutes in the recovery unit and in the ward for half an hour until discharge from the hospital. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Shetai

Esfahan University of Medical Sciences

hamidshetabi@med.mui.ac.ir+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026